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Vinod K. Sahney 
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When states consider "universal" health plans or plans serving more 
limited populations, the definition of covered benefits plays a key role 
in determining the plan's feasibility. In this chapter, considerations about 
benefit packages, limitations of coverage, cost-sharing characteristics, 
and covered services are discussed, and a method for estimating pro 
gram costs is presented.
Types of Benefit Plans
There have traditionally been three main types of health benefit plans: 
indemnity plans, service benefit plans, and prepaid or capitated plans 
(Donabedian 1976). Although all three types of plans can provide 
coverage for the same range of health care services, there have been 
significant differences among them in how they function and what they 
ultimately cover.
An indemnity plan is one in which the insured individual pays a regular 
premium to an insurance company in return for a promise of cash 
payments should certain defined, insurable events occur. For instance, 
the insurance company will agree to pay a certain amount for each day 
of hospitalization, a certain amount for a given outpatient procedure, 
or a certain amount for a routine office visit.
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The agreement is only between the insured individual and the insurance 
company. The individual is responsible for making payment to the 
hospital, physician, or other provider for services rendered, and the 
insurance company provides reimbursement to the insured individual 
according to the terms of the contract. The amounts of payment are 
part of the contract, and the individual is responsible for any bills in 
excess of the agreed upon amounts.
In a service benefit plan, the arrangement is slightly more complex. 
In return for the premium, the insured individual is entitled to a defin 
ed set of health care services (that is, days of hospitalization, outpa 
tient treatments, or prescription drugs). The range and level of services 
are spelled out in the insurance contract, but no fixed dollar amount 
is assigned to each. To meet its obligation, the insurance company must 
have another set of agreements in place with providers (hospitals, physi 
cians, and other providers) to actually perform the services that repre 
sent the policy's benefits. The insurance company reimburses the pro 
viders for services rendered. Providers may or may not bill patients 
for balances of charges over what the insurance company will pay.
In a prepaid or capitated plan, insured individuals pay a fixed premium, 
or membership fee, in return for access to virtually all necessary health 
services provided by members of an organized provider network. De 
pending on the nature of the relationship between insurer and providers, 
there may be varying degrees of financial risk on the part of providers. 
At one extreme, all the members' payments go directly to the provider 
organization, which.in turn is obliged to provide all necessary care and 
absorb any losses due to excess of expenses over revenues. At another 
extreme, providers continue to receive fee-for-service or per diem 
payments for services rendered, and the insuring entity takes on the 
full risk of gain or loss. From the patient perspective, these arrangements 
are relatively transparent, since patients are not responsible for any 
payments beyond the premium or membership fee.
These three types of benefit plans have different sets of advantages 
and disadvantages in terms of administrative overhead, freedom of choice 
of providers, and sharing of risk among patients/members, insurance 
companies, and providers. Very broadly speaking, capitation plans usual 
ly provide the broadest coverage, most restrictions on choice of
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providers, least amount of administrative overhead, and least risk of 
out-of-pocket expenses for the patient. Indemnity plans typically pro 
vide much more freedom of choice among providers, but higher 
administrative costs, more restricted benefits, and higher risk of out- 
of-pocket expenses in the event of very serious, expensive illness. Ser 
vice benefit plans share some of the features of indemnity plans, but 
may have even higher administrative overhead because of the need to 
process claims information among three parties the company, the 
patient, and the provider.
A state-run health care plan could conceivably be based on either of 
the three basic benefit models, some combination of the three, or perhaps 
some new model entirely. Choice of model involves some purely 
technical decisions about how a set of benefits is to be provided most 
economically, but also involves more value-laden decisions to be made 
in the political arena. These decisions include: how much choice of pro 
viders beneficiaries will have; how much of the current claims-processing 
infrastructure of existing insurance companies is to be maintained; and 
how much financial risk is to be the responsibility of the various par 
ties involved in the benefit program.
Benefit Limitations
The design of a health care benefit package must include considera 
tion of what type of limits will or will not be imposed. Some examples 
of limits in a benefit package include total dollar amount limits, limits 
on the number of inpatient days, and limits on the number of outpatient 
visits. Limits are typically imposed to deter overuse of the system by 
both the patient and provider and to put a ceiling on the financial risk 
of the insurer. However, due to extreme cases and unique individual 
circumstances, limits do not always control use and costs.
In choosing to impose limits in a state program, policy makers must 
consider consequences not only in costs, but also in overall utilization 
patterns and health status. For example, limits on the number of covered 
outpatient visits could control costs in that area but yield sicker patients 
upon admission to a hospital. Limits on the number of inpatient days
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and/or dollar amount limits could lead to earlier discharges and an in 
creased number of outpatient visits. As Donabedian (1976, p. 379) 
pointed out, "a long list of services is not a sufficient indication of com 
prehensiveness; stringent limits on the amount of each benefit can cripple 
the effectiveness of the whole."
In addition, dollar limits on benefits will affect the willingness of pro 
viders to render services. Physicians may refuse to offer any services 
to those with severely restricted benefits without assurance that the pa 
tient will be able to pay for any needed care additional to that included 
in the plan (Donabedian 1976, p. 386). Medicaid, an example of a very 
comprehensive benefit program in most states, often imposes a strict 
dollar limit on the amount paid to physicians and hospitals. This type 
of limit has been shown to lead to patient access problems (Donabe 
dian 1976, p. 264).
Cost-Sharing: Copayments and Deductibles
Health care cost-sharing means patients pay part of the cost of covered 
services through copayments and/or deductibles. A deductible is an 
amount of money the beneficiary must spend on health care before 
eligibility for health insurance benefits begins. Deductibles reduce the 
claims costs for insurers and may induce patients to avoid seeking care 
until they have serious symptoms or unless they are confident that they 
will exceed the deductible amount during the policy period, usually a 
year. Copayment, or coinsurance, is either a dollar amount or a percent 
age of a fee that the beneficiary pays at the time of each service. It may 
create the incentive to avoid prolonged, continuous, or intense care and 
perhaps to avoid the initiation of care as well (Donabedian 1976).
Cost-sharing helps insurers compensate for "moral hazard," or the 
tendency for the presence of benefits to change beneficiary behavior 
in a way that increases use of covered services, by making consumers 
of care somewhat responsive to its cost. Cost-sharing also reduces the 
cost of the benefit package and, presumably, the premium. Copayments 
and deductibles can reduce the administrative costs of claims handling 
because of fewer claims and because the insurer does not have to pay
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for any services until the beneficiary spends the deductible amount. Cost- 
sharing may increase costs for the provider, who may have to collect 
fees from two sources the patient and a third party (Donabedian 1976).
In a prepaid group practice (PPG), cost-sharing has been shown to 
affect the use of primary care but have less effect on the types and 
amounts of other types of office visits used (Gherkin, Grothaus, and 
Wagner 1989). Copays can reduce the inappropriate use of emergency 
rooms and unnecessary doctor's office visits. Even very low copayments 
can effectively prevent unnecessary use (Donabedian 1976; Shapiro, 
Ware, and Sherbourne 1986). Of course, there is a risk of causing the 
avoidance of appropriate use among the poor, particularly if copayments 
are too high, or avoidance of services such as preventive care that are not 
the result of an acute need. In addition, any delay in seeking care may 
result in patients being more sick when they do seek care and therefore 
requiring more intense and expensive treatment (Donabedian 1976).
The effects of cost-sharing measures depend somewhat on the method 
of provider payment. Since physicians influence the demand for their 
services and for health care services in general, the incentives they face 
will also affect utilization. To the extent that physicians consider costs 
to the patient in determining the appropriate course of treatment, pa 
tient cost-sharing may affect physician decisionmaking as well (Donabe 
dian 1976). The effects of cost-sharing in a capitated payment situation 
outside a PPG are not clear, although one might predict that they would 
depend on the sum of the incentives present. When physicians have an 
interest in the financial outcome of the plan, they might behave as PPG 
physicians. Similarly, under a prospective payment system for hospital 
inpatient care, patient incentives may be immaterial once the patient 
is hospitalized.
Cost-sharing has other characteristics. A given deductible or copay- 
ment amount will have a greater impact on someone with a lower in 
come than on someone with a higher income in terms of percentage 
of income spent. Similarly, the burden of copays is obviously greater 
on the ill. These redistributive effects, to use Donabedian's term, are 
the opposite of those we might endorse, if we would endorse any. When 
deductibles and copayments are substantial and/or when coverage is
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not comprehensive, total out-of-pocket expenditures by beneficiaries 
can be limited to a maximum dollar amount or a percentage of income 
by a catastrophic coverage provision. This would prevent financial ruin 
for the families that have a single or series of major medical events, 
the copayments amounts or uncovered expenses of which they would 
otherwise be unable to pay (Donabedian 1976).
Any discussion of appropriateness of use presumes that what is ap 
propriate can be satisfactorily defined, which is not necessarily the case. 
Most studies of the effects of these incentives measure use rates relative 
to another group. When health risk or health status is the criterion in 
stead, among adults the presence of cost-sharing mechanisms has a 
negative effect only for the sick and particularly the sick poor (Brook 
et al. 1983). Children's health has not been found to be affected by 
the presence of cost-sharing when total out-of-pocket spending is limited 
to a relatively small amount (Valdez et al. 1985).
The distribution of cost-sharing across a benefit package will influence 
the mix of services used, particularly in a fee-for-service payment en 
vironment. Even very small cost-sharing connected with ambulatory 
services is associated with lower use of these services and a high rate 
of hospitalizations among the poor, so that any cost savings on the am 
bulatory side may be overcome on the inpatient side (Roemer et al. 
1975). This type of manipulation of preferences may be helpful if the 
insurer wishes to encourage certain types of services it feels are relatively 
economical and/or effective, or to avoid services that may be the op 
posite. If this were to be done effectively, it would probably require 
the constant monitoring of the cost and effectiveness of various therapies, 
settings, and types of providers to assure the most appropriate ones are 
encouraged, and periodic adjustments to the cost-sharing mechanism. 
Such a program would probably not be necessary in a PPG, where the 
most cost-effective therapies are likely to be sought and utilized anyway. 
Prepaid group practices tend to provide more preventive care and have 
lower rates of hospitalization (Manning et al. 1984).
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Determining Covered Services
The services covered by a benefit package will influence the cost, 
health benefit, and acceptability to beneficiaries and providers of the 
health care program. This section will discuss issues surrounding the 
overall design of the coverage and particular benefits.
There are three main goals in designing a state health care program: 
to provide adequate access to services for the target population and en 
courage the appropriate utilization of them; to ensure that the quality 
of the care received is adequate; and to do so in the most economical 
way possible. These goals are not independent but interrelated, and the 
first two may conflict with the last. The resolution of this conflict is 
not objective or scientific, but political. The determination of what is 
adequate access and appropriate use is made in the public policy arena, 
in a context of cost, moderated by the concern with quality.
Access is achieved by having needed services available, in an accep 
table way, at an acceptable cost, and within an acceptable distance 
and time (Penchansky and Thomas 1981). What is "needed" is a mat 
ter for debate, but what consumers demand or perceive to be needed 
must be considered. Acceptability is also a flexible concept that must 
consider costs (both to society and the consumer), quality, and equity. 
The criteria by which a particular subpopulation should accept or be 
found to require a different standard of access from others need to be 
identified and examined. The payment and participation rates of pro 
viders and their geographic distribution will affect access. What benefits 
are covered and at what cost to the consumer are issues that will affect 
the consumer's perception of access, which will in some cases affect 
care-seeking.
Appropriateness of use of health care services can be measured by 
health outcomes such as infant mortality rates, life expectancy, disability 
days, and quality-adjusted life years (QALY). Of course, these outcomes 
are affected by other factors such as the quality of the services, genetics, 
lifestyle, age, the environment, socioeconomic status, and public health 
measures, so their value in evaluating health care itself is limited. We 
know that insurance coverage increases use of health care services, 
especially among the poor and the sick poor (Davis and Rowland 1983;
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Newachek 1988; Wilensky and Berk 1983), although the determina 
tion of an appropriate use rate or set of use rates remains normative.
Restricting Use
Plan features restricting use are intended to reduce wasteful or harmful 
care and control costs. A benefit package can be designed to limit the 
use of some providers, such as chiropractors or podiatrists, or of some 
modes of care, such as home care or nursing home care. Insurers may 
use these restrictions to control their costs, which allows them to main 
tain competitive prices, market shares, and acceptable margins. This 
also has the effect of creating and/or maintaining monopoly power and 
markets for some providers and types of care at the expense of others.
The abhorrence of the idea of rationing health care by ability to pay 
is one reason for the interest in the financing of health care services 
for those now uninsured. This interest results from the evolving notion 
of health care as a right rather than a market good (Callahan 1988; 
Reinhardt 1986). Credible proposals to make rationing on the basis of 
age an explicit public policy have been made (Callahan 1987; Aaron 
and Schwartz 1984) and public debate has begun, but resolution of this 
issue does not seem near by any means.
The effect of the breadth and depth of the benefit package, or its com 
prehensiveness, on demand for and use of services is important. If the 
package is not broad enough (i.e., doesn't have a wide spectrum of 
covered benefits), it will not encourage efficiency and the types and 
amounts of use that will maximize the beneficiary's health, well-being, 
and productivity. There will be a tendency, on the part of providers and 
beneficiaries, to utilize covered services and avoid services not covered, 
even if the covered services are inefficient or less effective substitutes 
for the preferred therapies. This issue is probably more important to 
states than to private insurers because the states are traditionally respon 
sible for supporting the disabled and medically indigent. Also, if the plan 
does not protect participants and providers from financial ruin in the 
event of illness or injury, no matter how catastrophic, it will not be 
doing what health insurance in its most basic form is supposed to do.
One problem with offering a broad benefit package is that, as costs 
rise, there is financial pressure to reduce the number of people covered.
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This is because the total program costs equal the price of the services 
offered times the number of services delivered. As costs of the Medicaid 
benefit package have increased, for instance, most states have adjusted 
eligibility requirements so those benefits are provided to a population 
small enough not to exceed budget limitations.
Oregon is trying to reverse this process by limiting the benefits they 
provide to a predetermined population (Beck, Joseph, and Hager 1990). 
They have attempted to determine an appropriate and acceptable benefit 
package by prioritizing covered services according to the expressed 
preferences of state residents. Through a series of 50 meetings held 
around the state, over 1,000 residents learned about and expressed their 
preferences with regard to different therapy options for diseases and 
their outcomes (Crawshaw et al. 1985). The results of these meetings 
were tabulated by computer to generate a list of services that could be 
covered, from highest to lowest priority.
Once this list is finalized, the state legislature intends to determine 
the cost of coverage for the population they will cover and, using 
budgetary constraints, to draw a line through the list, which will then 
define the extent of the benefit package (Beck, Joseph, and Hager 1990). 
While this process has not cleared all of its administrative hurdles- 
most important, the receipt of a waiver from the Health Care Financ 
ing Administration so it can continue to receive federal contributions 
to its Medicaid program costs it represents an innovative and impor 
tant step toward the rationalization of health care benefits package and 
program design.
Specific Benefits
Vision and Dental Care
Vision and dental care benefits are often omitted from health care 
plans to cut costs, on the assumption that their absence will have little or 
no impact on the general health of the patient. The importance and value 
of these benefits may not be appreciated. "People seldom die for lack of 
dental care, but the quality of their lives can be compromised by lack 
of appropriate care" ("Dental Coverage Affects Usage, Expenditures"
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1989). Another reason these benefits are absent from most health care 
benefit packages is that vision and dental care costs are largely 
foreseeable and can be planned for (Bell 1980).
The results of partial coverage or no coverage of vision care under 
a universal health plan will not impact the entire population. However, 
in design of a universal plan, the fact that half of the population in the 
United States wears corrective prescription lenses must be taken into 
consideration ("Vision Care Plans" 1981). For those persons who are 
unable to afford corrective lenses, partial coverage or a lack of coverage 
may result in going without glasses or postponement of needed exams, 
and thus the eye condition may worsen. On the other hand, inclusion 
of vision care in a universal plan can yield important benefits. The Rand 
Health Insurance Experiment demonstrated that free vision care resulted 
in improved vision by increasing the frequency of eye examinations 
and lens purchase. It is probable that the increased visit rate on the free 
care plan resulted in increased detection of diseases (Lurie et al. 1989).
In the design of a universal health care plan, the question of cover 
ing dental care is difficult. "Dental care may be assumed to have main 
tained its traditional positive relation to income because it has been 
regarded by individuals and by society as a more discretionary item, 
more akin to a luxury than a necessity" (Donabedian 1976, p. 24-25).
Dental plans in general are purchased separately from health insurance 
plans. The need for dental care is usually predictable and ongoing, rather 
than episodic like acute health care. According to the American Dental 
Association, dental benefits differ from medical plans in that dental 
disease is preventable; early intervention is most efficient and least costly; 
and the need for care is ongoing and universal ("Coalition, ADA Set 
Standards for Dental Plans" 1989).
Both dental and vision care are benefits that can be excluded from 
a health insurance plan with little or no impact on an indicator such 
as mortality, but could have significant impact on health status/quality 
of life. However, it may be more cost-efficient to include preventive 
services in both dental and vision care, thus preventing more expen 
sive treatment in the long term. While health benefits result from in 
cluding these services in a health care benefit package, the relationship
Benefit Package Considerations 163
between the benefit and the cost to the state, or any purchaser, is not 
clear.
Mental Health and Substance Abuse
Use of mental health and substance abuse services by employees and 
dependents is soaring. According to the National Institute of Mental 
Health, one of every five Americans now needs professional mental 
health services, where only one in eight needed such professional help 
in 1960 (Montgomery 1988). The stigma that was once associated with 
seeing a psychiatrist or psychologist is no longer as apparent today. 
Thus, an increase in usage of behavioral health services has caused 
employers and insurers to look more closely at the cost implications 
of enhancing coverage that presently exists or including such benefits 
in a current plan.
Along with an increase in usage, there has been a definite increase 
in health care dollars being spent on these benefits. Mental health and 
chemical dependency treatment costs are increasing by more than 15 
percent each year (George-Perry 1988). Mental health and substance 
abuse treatment coverage in health insurance plans have typically been 
for expensive inpatient care. To deter some of these increasing costs, 
plans are moving towards more and/or better coverage of outpatient 
treatment in both of these areas (Frabotta 1989). Outpatient care has 
been shown in some studies to be less expensive in the long term and 
to have results that are equal if not better than inpatient care. "Rather 
than spending $6,000 to $8,000 for an inpatient stay, employers may 
only have to spend $2,000 to $3,000 for a well-structured, medically 
supervised outpatient program, while keeping the patient on the job" 
(Frabotta 1989).
Lack of coverage or partial coverage for behavioral health services 
will not keep people from being seen in the system. Prior to introduc 
tion of specific coverage, and even now with insured groups without 
coverage, alcoholism was sometimes treated under other "surrogate" 
diagnoses covered by insurance (Morrisey and Jensen 1988). This type 
of surrogate treatment is seen with both mental health and substance 
abuse services.
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Various studies have shown that benefits such as mental health and 
substance abuse actually reduce medical care utilization. "The 
longitudinal pattern of total health care costs illustrates that a marked 
increase in such costs among individuals with mental health problems 
can be expected over the 36-month period prior to initiation of treat 
ment. A decrease in total health care can be expected following the start 
of mental health treatment even when costs of this treatment are in 
cluded" (Holder and Blose 1987). A four-year longitudinal analysis 
of federal employees showed a decline in health care costs after initia 
tion of treatment. After examining the claims of nearly 1,700 treated 
alcoholics and their families, one study found that, after an increase 
in costs associated with treatment, cost for many alcoholics eventually 
declined to a point comparable with the lowest pretreatment levels 
(Holder and Blose 1986).
The inclusion of such benefits in an insurance plan may decrease total 
health care costs and be beneficial; however, it may be necessary to 
implement limits to have some type of control on utilization of these 
services. The open-ended nature of psychiatric treatment frequency in 
vites continuation of outpatient contact with the therapist far beyond 
the point of symptom remission (Montgomery 1988).
Prescription Drugs and Contraceptives
Prescription drugs are covered under many health insurance plans 
with little or no copayment. However, prescription coverage, once view 
ed as a small investment that brought about large returns, is now being 
reconsidered, and tighter controls are being implemented. The reason 
is that the cost of coverage is rising. For many companies, the cost of 
covering prescription drugs has risen faster than any other component 
of their health benefits package except mental health and substance abuse 
treatment (Vibbert 1989). Covering prescription drugs without any type 
of utilization control mechanism can result in high costs under a universal 
plan. On the other hand, not covering prescription drugs under this plan 
may have effects on health. The lack of prescription drug coverage could 
affect some persons more than others for example, those below a certain 
income level who just cannot afford such "extras" as prescription drugs.
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In many plans, contraceptives fall under the category of prescription 
drugs; however, they may be viewed as a separate benefit in the design 
of a health insurance plan. Many insurance plans are beginning to drop 
coverage of contraceptives due to the cost that this coverage adds to 
the premium (Muller 1978). Offering coverage of contraceptives as 
prescription drugs will add to the cost of a plan in the near term, however, 
in the long term it may decrease utilization of obstetrical and pediatric 
health care services.
Experimental Procedures
Treatments and procedures considered experimental are generally ex 
empted, or not covered, by health care plans (Ham 1989). The deter 
mination of whether or not something is experimental is made in several 
ways, but it is common for insurers to follow the example of the Health 
Care Financing Administration, which makes this determination for the 
Medicare and Medicaid programs. If exempted, a procedure may be 
available to those who have the ability and willingness to pay for it out- 
of-pocket or to those who can find and are eligible for participation 
in a funded research project that will pay for it. The rationale for not 
covering these treatments is that their efficacy and safety have not been 
proven, and their use is not widely accepted. In addition, they tend to 
be expensive. Since these therapies are not widely available, states should 
have little problem exempting them from the benefit package. There 
is not an equity issue since others do not have access either, and there 
is a cost and quality interest in not covering care until it is shown to 
be safe and have a useful place in the medical armamentarium.
Transplants
The coverage of organ and tissue transplants has received considerable 
attention. Both Arizona and Oregon have restricted coverage of 
transplants for their Medicaid recipients. Considering the high costs 
and the poor cost-effectiveness of some of these life-saving or sustain 
ing procedures compared to other potential uses of funds, noncoverage 
may be a rational choice (Durbin 1988). On the other hand, since most 
private insurance plans cover at least some and usually most of the costs
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of such procedures, and some transplants may be more cost-effective 
than the alternative therapies for the afflicted individuals, noncoverage 
raises equity and discrimination issues (Durbin 1988). In the context 
of a universal plan, these issues would be less potent because the same 
coverage would apply to everyone. When participants in the plan are 
disproportionately of a particular socioeconomic status or racial or ethnic 
group, special effort may be needed to avoid the appearance or fact 
of discrimination.
New Technology
One of the effects of a "free market" medical system has been the 
development of new technologies, especially in the areas of phar- 
maceuticals, surgical procedures, biotechnology, and imaging. 
Treatments constantly emerge for conditions previously considered un- 
treatable, and new and innovative treatments replace old (McGregor 
1989). This march of technology is a source of both pride and con 
cern. While these technologies are largely responsible for our health 
care system being seen as the best in the world, they also are a central 
reason for the tremendous costs and inflation experienced in the health 
care sector. They also tend to shift resources away from prevention 
and primary care (Somers 1984). That private insurers generally pro 
vide coverage for new technologies only on the basis of efficacy and 
availability without regard to costs certainly contributes to this dilem 
ma (Ham 1989). While not all of these technologies are as expensive 
as Positron Emission Tomography or AZT, they all contribute to the 
health cost spiral (Moloney and Rogers 1979).
When sick, Americans expect access to the latest and most innovative 
technology, even when its cost outweighs any incremental benefit that 
may be achieved over the technology it replaces. An example is elec 
tronic fetal heart monitoring, which is widely if not routinely used, even 
though its benefits are unproven (Shy et al. 1990). For this reason, it 
would be difficult to exclude coverage of new technologies in a com 
prehensive state benefit package. There are several strategies for con 
trolling the use of these technologies. One approach would be to re 
quire prior approval for the use of specified procedures on a case-by- 
case basis. This could operate similarly to prehospitalization certification
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programs whereby the payor must approve any nonemergency hospital 
admission. Copayments and/or deductibles could also be attached to 
discourage overuse. Still another strategy would put the provider at finan 
cial risk for the use of the procedure or technology through a capitated 
or case-based payment system (Moloney and Rogers 1979). The use of 
cost-effectiveness analysis remains an untried and potentially potent basis 
for such allocative decisionmaking (Emery and Schneiderman 1989). 
It would be a mistake, however, to take the view that it is only new 
or high technology that is responsible for an increase in costs of 
treatments. Increases in the use of existing technology, such as X-ray 
examinations and laboratory tests, are as likely to be culprits. Strategies 
to limit the use of technology are best if they apply to any type. Ex 
amples could be capitation of case-based payment or broad-utilization 
review (Moloney and Rogers 1979).
Rehabilitation
After a disabling injury or illness, such as an auto accident or a stroke, 
patients may be discharged from the hospital without need of continu 
ing medical care but still unable to resume life as before. Although many 
of these individuals ultimately will be unable to recover fully, they may 
still be able to lead personally fulfilling and socially productive lives, 
provided they receive the rehabilitation services required. There are 
other sources of financing for rehabilitation services. In some states, 
the no-fault auto insurance program may include this coverage in the 
event of an auto accident. Workers' compensation insurance provides 
this coverage for injuries that occur in the workplace. Still, there are 
circumstances outside of these environments, such as strokes, and ac 
cidents other than motor vehicle, when the services necessary to max 
imize a patient's potential is not accessible due to lack of financing. 
This is a particularly important issue for states, which, unlike private 
insurers, are traditionally responsible for the welfare of their citizens, 
have a potential tax-generating workforce in need of services, and have 
to pay a proportion of Title XIX program costs of those who remain 
disabled. If states already have a rehabilitation program in place, the 
effect of this coverage on its costs should be considered.
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Rehabilitation services can be rationed in several ways. A common 
method is to set a time limit after which services would no longer be 
covered or a set number of services or amount of dollars allowed. This 
can be seen as discriminatory against those who, while significant 
recovery is expected, have injuries that necessitate longer or more in 
tensive rehabilitation. Another way would be to provide coverage for 
only a specific set of services based on the prognosis, or to make a deter 
mination of coverage based on the prognosis and the expected rehabilita 
tion time or expense. Someone whose rehabilitation would take a shorter 
time and who is expected to make a more complete recovery would 
have services covered, while others may not. Prognosis accuracy would 
be important in both of these situations, which may be a problem. Age 
and social role could also be considered in such decisions.
The costs associated with transplants, new technology, and rehabilita 
tion may be most appropriately managed in the context of a program 
for catastrophic health care cost protection. These rather extreme sources 
of high costs are singled out, perhaps because they affect a very small 
number of people. Chronic disease treatment and intensive care also 
involve very high expenses, but there is no suggestion that they be ex 
cised from the health care package. On the contrary, they are impor 
tant reasons for having coverage. Efforts to control costs may be more 
effective and fair through a systemwide approach to efficiency, utiliza 
tion management, and prevention than by the narrowing of the benefit 
package at its margins where those with great need are denied and emo 
tional responses and inflammatory press coverage are likely.
Home Health Care
Home health care has become an important low-cost substitute for 
hospital and nursing home care. Therapies that were once considered 
strictly inpatient, requiring high levels of nursing skill, have found their 
way into the realm of home care. Patients can be safely discharged home 
from the hospital earlier when regular skilled nursing care is available 
in the home (American Medical Association Council on Scientific Af 
fairs 1990). This can bring considerable cost savings to the pay or while 
improving outcomes (for instance, through the avoidance of nosocomial 
infections) and patient satisfaction. Additional costs can occur, however,
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when home care is sought that is not a substitute for other medical care. 
This is an example of the effect of "moral hazard," because demand 
seems to come as a result of the provision of coverage. It is not clear 
in these circumstances whether this demand represents substitution for 
family care or for impending medical care. If it is a substitute for future 
hospital care, it may represent a source of additional savings in the long 
run, rather than a liability.
The use of home health care can be restricted, for instance, by only 
covering services provided after a hospitalization, and then for a limited 
time, as Medicare does, and/or by attaching cost-sharing provisions. 
Requiring prior approval by the payer would be another strategy. Home 
health care is such a valuable and efficient model of care that its coverage 
should probably be considered essential to even a basic health plan, 
even if restrictions are attached.
Durable Medical Equipment
Like home health care, durable medical equipment (DME) is a 
valuable service for beneficiaries that can reduce the cost of care but 
has potential for overuse or abuse. By providing respiratory therapy 
equipment, wheelchairs, walkers, special beds, and appliances, the well- 
being and quality of life of patients can be enhanced. In some cases, 
these services represent less intensive treatment methods than would 
otherwise be employed, and thereby represent a cost savings. When 
improved comfort and well-being improves health and avoids the need 
for other forms of care, additional savings may accrue, although this 
has not been quantified. The downside is that these services may be 
used unnecessarily just because they are available, or as substitutes for 
goods or services that would have otherwise been paid for out-of-pocket. 
Cost-sharing may also be applied here, as well as utilization manage 
ment or risk-assumption by the provider.
Estimating Costs of a State Health Care Program
With the above considerations in mind, estimates of costs for a benefit 
package to be offered under a state-sponsored plan can be generated. 
Estimates are useful for considering the effects of variations in a benefit 
package and other elements of a program on its overall costs. As an
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example, we estimated the cost of covering Michigan residents under 
65 with a comprehensive package for implementation in 1990 or 1991.
Data Sources
One way to estimate costs would be to estimate utilization rates bas 
ed on known averages and apply a per-service cost model to calculate 
overall costs. This requires realistic estimates of costs, which are dif 
ficult to obtain, and assumes that patterns of use will not be affected 
by a new program. Another way to estimate costs would be to use known 
per-patient costs and apply them to the target population.
We found data on the latter to be readily available through a state 
health maintenance organization (HMO) regulating agency. Few non- 
HMO plans provide a comprehensive set of benefits, particularly for 
outpatient care and preventive services. HMO plans provide the best 
and most current data on the costs of this type of package.
While Medicaid also offers a comprehensive benefit package, its 
unique demographics, the large concentration of elderly and disabled, 
possible differences in utilization (for example, lower use of services 
because of access problems), lack of controls on utilization, and 
unrealistic provider payment make its experience a poor basis for cost 
projections to the whole population.
We estimate the costs of benefits with data from the 1989 rate filing 
of Blue Care Network (BCN), Michigan's second largest HMO. This 
HMO's data were used because:
1. This large HMO has subscribers throughout most of Michigan. Its 
cost experience may be more typical of what could be expected under 
a statewide plan than that of HMOs that serve a limited geographic 
area or have very small enrollments.
2. The division of the plan into geographically defined subunits allows 
a comparison of costs of care in different areas of the state.
3. Comparisons of BCN and other HMOs showed that it is typical in 
having neither the highest nor lowest per-member per-month (PMPM) 
costs.
4. These data reflect managed care delivery as proposed for the Michigan 
plan. BCN is typical of the sorts of plans offered if consumers are
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allowed to choose from among several certified health care plans. 
As a network-model HMO, Blue Care Network does not have all 
the cost-containment features of staff- or group-model HMOs, but 
has some not found in purely fee-for-service plans. Its experience, 
therefore, is a middle ground between the most and least efficient 
financing and delivery system models.
5. BCN subscribers are diverse. The plan is not restricted to white- or 
blue-collar employees, and most age and economic groups are 
represented.
The benefit package used is summarized in Table 1. Using specific 
health plan data requires caution. Some caveats and issues we considered 
are:
1. Projections were based on 1988 data. Utilization rates and costs per 
unit of service or the data itself may have been anomalous for some 
reason that year. More precise forecasts using these data would con 
sider the relationship of the 1988 data to both 1987 and 1989.
2. We did not usually have information on exactly what costs are 
reflected in the costs per unit of service that are a part of the monthly 
cost estimate. These are provider costs that may change in a number 
of unpredictable ways under a state health plan. There might be reduc 
tions in inpatient care costs due to eliminating uncompensated care, 
reduced billing costs, or lowered malpractice costs.
3. Dentaland vision care costs do not come from Blue Care Network. 
The costs of dental coverage are from 1988 information for Blue 
Cross-Blue Shield. The costs of vision coverage are from the 1988 
rate filing of Comprehensive Health Services of Detroit, a Detroit 
HMO. In both cases the costs represent an approximation of a me 
dian cost estimate neither the highest nor lowest cost for this benefit.
4. The average cost figure shown for the benefit package is an un 
weighted average of the costs of these benefits from six BCN regional 
plans. The average was not weighted for the size of the enrolled 
population because the largest plan occasionally had specific benefit 
costs that were unusually high or low when compared to either the 
other Blue Care Network plans or other HMO rate filing information.
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Table 1 




Hospital charges (unlimited days, semi- 
private room, and specialized units) $23.82 
Professional services 8.30 
Outpatient 
Office visits (including preventive, urgent
and specialist care) $5.00 16.87 
Diagnostic services (X-ray and lab work) 7.52 
Outpatient surgery 4.31 
Allergy testing/serum 50% 0.15 
Other outpatient services $5.00 1.49 
Reproductive health
Adult sterilizations 50% 0.15 
Elective terminations 50% 0.07 
Mental health
Inpatient mental health 1.30 
Inpatient substance abuse 50% 0.80 
Outpatient mental health 50% 1.42 
Outpatient substance abuse 50% 0.53 
Emergency care
Emergency care $25.00 2.71 
Ambulance 0.47 
Other
Skilled nursing facility (up to 45 days) 0.08 
Home health agency $5.00 0.35 
Durable medical equipment 20% 0.27 
Pharmacy (including needles, syringes
and birth control) $3.00 9.51 
Other services 1.05 
Dental 10.51 
Vision 1.77 
Benefit total $93.48 
Reinsurance 1.15 
Administration and retention (16%) 15.14
TOTAL $109.77
*per member per month.
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An unweighted average seemed more likely to yield a conservative 
estimate of the future cost of benefits.
5. Not all benefits were offered in all plans in most cases because ser 
vices were offered under one of the other benefit categories (for ex 
ample, urgent care could have been a separate category or included 
under an office visit category). Most of these differences are resolv 
ed by combining the categories into a single benefit, others by leav 
ing zeroes out of average cost calculations. The result is an average 
that is slightly higher (or more conservative) than the average that 
would have been calculated from each of the plans' total costs.
Adjustment in Estimates to Project Costs 
for a State Program
Before data from an existing plan are used to project costs for a state 
program, it is necessary to determine if there is a selection bias present 
in the plan membership that would affect cost projections. The member 
ship of the plan used to model costs must match the population to be 
covered by a new program in factors that predict utilization and costs 
or be adjusted to compensate for differences. Table 2 summarizes 
demographic differences between the 1988 BCN enrolled population 
and the 1990 projections for the entire State of Michigan. There are 
only minor differences in the age and gender composition of the 
populations.
Based on the small differences between the BCN and Michigan popula 
tions, no adjustment appeared necessary. Variations seem to have ef 
fects on health care costs that would balance each other. BCN has more 
women of childbearing age and adults between 55 and 64 (higher costs), 
but also more children (lower costs). Therefore, based on the age and 
sex distributions of its membership, this plan seemed to be a reasonable 
basis for projecting overall costs for the state of a universal plan.
Variation in Costs by Region of the State
An important issue to be worked out during discussion of a state plan 
is the extent to which the state will wish to adjust its contribution on 
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Michigan would be reasonable if a single, statewide plan were im 
plemented. If, however, individuals were allowed to choose from among 
several plans that may serve limited areas, state contributions or 
allowable premiums may be adjusted for regional variation in costs. 
In a previous analysis we found rates for a large commercial insurer 
varied by area within Michigan as shown in Table 3. There was much 
less cost variation between BCN regions, and the Southeast region 
(Detroit and its suburbs) did not have the highest projected costs. Since 
costs of coverage are a function of several factors, including 
characteristics of the enrolled population, use rates, costs per unit of 
service, and costs of plan administration, it is difficult to do further 
analysis of cost variations within the state for a universal plan until more 
specific information is available. It may be that the lower costs of benefits 
in areas such as the Upper Peninsula may be balanced by higher ad 
ministrative costs there due to low population density.
Table 3 
Regional Variations in Premiums
Area Rate multiplier
Upper Peninsula, some Northern Lower 1.00
"Outstate" Lower Peninsula 1.07
Lansing, Kalamazoo, "Downriver" areas 1.14
Macomb, Oakland, Washtenaw counties (suburban Detroit) 1.25
Wayne County (includes City of Detroit) 1.38
Costs of Individual and Family Coverage
Our best current estimate is that a figure of approximately $110 per 
month per person would be a reasonable projection of the 1989 costs 
of a comprehensive health care plan for a large group with demographics 
like those of the Michigan population (including children, not including 
individuals over 65). Projected premiums for single adults and families 
are determined by applying multipliers to the average PMPM cost ac 
cording to how costs are to be distributed across these groups. An ex 
ample is shown in Table 4.
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Table 4 
Determining Premiums for Beneficiary Groups
Group





=Base x 1.25 







Precision of Cost Estimates
The accuracy of estimates of the costs of coverage for a proposed 
program depends on several factors for which our data were incomplete:
  health status and utilization patterns of group to be covered
  delivery system(s) in which care is to be provided
  whether payment will be based on premiums charged by insurers, 
including all administrative expenses, or a reduced premium which 
does not allow recovery of all insurer costs, or a rate pegged more 
closely to the costs of providing care
  whether providers will be reimbursed on a charge basis, an ' 'allowable 
fee" basis, a capitation basis, or some sort of partial recovery basis 
less than full costs
  additional cost-containment features that may be built into the design 
of the plan.
There are some clear tradeoffs between costs of coverage, extent of 
coverage, and the administrative and delivery system structures 
associated with any plan. In our example, $110 per-person per-month 
can purchase very extensive coverage in most areas of the state under 
circumstances exemplified by Blue Care Network. It will purchase much 
less extensive coverage in a high-cost area of the state and/or under 
plans with higher administrative costs (for example, individual or small- 
group coverage).
Finally, it must be considered that implementation of a state plan may 
itself affect costs. Here are some ways that the plan can distort its own 
costs.
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1. As uninsured individuals become covered, a short increase in de 
mand for services could occur, resulting in higher-than-normal costs 
due to "pent-up" demand.
2. The burst of demand may meet some serious shortages of health care 
providers, particularly nurses in acute-care settings and physicians 
in areas that are currently underserved. Not all individuals seeking 
care and covered by the state plan will be able to get it quickly. The 
increase in use will therefore be moderated in the near term, but will 
last as long as there continues to be a demand backlog.
3. If features of a state plan create a significant restriction on physician 
incomes, an exodus of physicians may occur if it is not countered 
by f other changes making practice in the state more desirable. Any 
migration will affect access to care and in turn program costs and 
the program's ability to meet its objectives.
There are other possible effects of implementation that are impossi 
ble to predict with any certainty until the features of a plan are made 
more specific. As discussion and planning move forward, it will be possi 
ble to adjust cost estimates to reflect how plan features relate to utiliza 
tion and costs per unit of service.
It is difficult to accurately predict how changes in some of these fac 
tors will affect costs of providing care. Our estimates of the costs of 
providing services under managed care conditions in the Blue Care Net 
work environment are based on patterns of use and costs of providing 
services specific to BCN. If conditions change drastically under a state 
plan, simple linear projections of past trentis to future costs, while they 
may be the best estimates available, will be subject to more than the 
usual amount of error. The purpose of these analyses is to roughly 
estimate the effects of various benefit combinations on the overall pro 
gram costs to a state. They are not intended to be the basis for budgeting. 
As plans move closer to implementation, more precise and actuarially 
sound cost calculations must be performed.
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Conclusion
The design of a benefit package will affect every aspect of a pro 
gram: its success at meeting its health and social objectives, such as 
financial equity for providers, income redistribution, and improvement 
in the health status of target populations; its costs and their distribution 
between payors, patients, and providers; and (therefore and inevitably) 
its political viability. A well-conceived benefit package can remove am 
biguity about the goals of a program and its expected costs and 
advantages.
Accomplishing this requires that knowledge of the effects of benefit 
features be injected into a process of values clarification about program 
goals that is essentially political. Priority-setting with regard to 
beneficiaries (providers, payors, and patients), and benefits (consider 
ing implicit rationing from restricted coverage) can be assisted by the 
provision of information about the costs and effects of specific benefit 
changes.
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